PPD development LP:1106692 [18-007540]
Ended Awarded Last action
- Contract number
- 75N95018F00001
- Awardee
-
PPD Development LP UEI ZANENSW6C665
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $347,500
Award facts
- Opportunity
-
- N01TR172004 Solicitation number
- CRO Support for NCATS Bioanalytical Method Development for Biologics Award Notice · Posted Jan 11, 2017
- Contract value 100% obligated
- $347,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cape Fear, NC 28401, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$78,400 | |
| Funding Only Action | -$17,000 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $78,400 | |
| Original award | $364,500 |
About this award
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PPD Development LP, a global contract research organization. The contract has a value of $347,500.00 and is a delivery order under the CRO Support for NCATS Bioanalytical Method Development Indefinite Delivery Contract (IDC). The contract provides clinical trial and research support services, including areas such as regulatory management, clinical trial monitoring, data management, and analytical testing services supporting vaccine, therapeutic, and medical countermeasures development and evaluation. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95018F00001?
75N95018F00001 was awarded to PPD Development LP by National Institute on Drug Abuse (National Institutes of Health) on September 24, 2018.
How much is contract 75N95018F00001 worth?
The government has obligated $347,500 on 75N95018F00001.
Which agency awarded contract 75N95018F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95018F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95018F00001 an order under another contract?
Yes. 75N95018F00001 is a delivery order under HHSN271201800007I, an indefinite delivery contract, on CRO Support for NCATS Bioanalytical Method Development.
Was contract 75N95018F00001 competed?
The extent of competition for 75N95018F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award